# Kenneth W. Mahaffey

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kenneth-w-mahaffey/

## Facts

| Field | Value |
| --- | --- |
| Citations | 101,308 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 134 |
| i10-index | 531 |
| Last Known Institution | Cardiovascular Institute of the South |
| OpenAlex ID | https://openalex.org/A5039432822 |
| ORCID iD | 0000-0002-3791-2148 |
| Works | 1,040 |

## Researcher papers

Showing 12 of 39.

- [Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation](https://scholariq.org/papers/rivaroxaban-versus-warfarin-in-nonvalvular-atrial-fibrillation/)
- [Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-events-in-type-2-diabetes/)
- [Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/ticagrelor-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation](https://scholariq.org/papers/esc-guidelines-for-the-management-of-acute-myocardial-infarction-in-patients/)
- [Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy](https://scholariq.org/papers/canagliflozin-and-renal-outcomes-in-type-2-diabetes-and-nephropathy/)
- [Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome](https://scholariq.org/papers/alirocumab-and-cardiovascular-outcomes-after-acute-coronary-syndrome/)
- [Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation](https://scholariq.org/papers/large-scale-assessment-of-a-smartwatch-to-identify-atrial-fibrillation/)
- [Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes](https://scholariq.org/papers/effects-of-semaglutide-on-chronic-kidney-disease-in-patients-with-type-2/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis](https://scholariq.org/papers/sglt2-inhibitors-for-the-prevention-of-kidney-failure-in-patients-with-type-2/)
- [ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use](https://scholariq.org/papers/accf-acg-aha-2008-expert-consensus-document-on-reducing-the-gastrointestinal/)
- [2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials](https://scholariq.org/papers/2017-cardiovascular-and-stroke-endpoint-definitions-for-clinical-trials/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Researcher university

- [Cardiovascular Institute of the South](https://scholariq.org/institutions/cardiovascular-institute-of-the-south/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.